about
Increased expression of urokinase plasminogen activator and its cognate receptor in human seminomasAurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT.Q-elastography in the presurgical diagnosis of thyroid nodules with indeterminate cytologyDeregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients.Association of thyroid diseases with primary extra-thyroidal malignancies in women: results of a cross-sectional study of 6,386 patients.Thyroid Imaging Reporting and Data System Score Combined with the New Italian Classification for Thyroid Cytology Improves the Clinical Management of Indeterminate NodulesThe urokinase plasminogen activator system: a target for anti-cancer therapy.Emerging molecular markers for the prognosis of differentiated thyroid cancer patients.Update on the role of ultrasound guided radiofrequency ablation for thyroid nodule treatment.New perspectives in the diagnosis of thyroid follicular lesions.Preclinical testing of selective Aurora kinase inhibitors on a medullary thyroid carcinoma-derived cell line.Nodular thyroid disease in the elderly: novel molecular approaches for the diagnosis of malignancy.Deregulated expression of VHL mRNA variants in papillary thyroid cancer.Effects of ultraviolet radiation on FRTL-5 cell growth and thyroid-specific gene expression.In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval.Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer.Total fistulectomy, sphincteroplasty and closure of the residual cavity for trans-sphincteric perianal fistula in the elderly patient.Difficulties in the diagnosis of thyroid paraganglioma: a clinical case.Vitiligo and Autoimmune Thyroid Disorders.Bloodless surgery in geriatric surgery.Staples versus subcuticular closure in cervicotomy incisions.Parathyroidectomy for primary hyperparathyroidism in the elderly: experience of a single endocrine surgery center.Endoscopic mucosal resection in elderly patients.Management of concomitant hyperparathyroidism and thyroid diseases in the elderly patients: a retrospective cohort study.Internet-based versus traditional teaching and learning methods.Advancement of thyroid surgery video recording: A comparison between two full HD head mounted video cameras.Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3,921 patients.Differentiated thyroid cancer in patients ≥75 years: Histopathological features and results of surgical treatment.Aurora-C interacts with and phosphorylates the transforming acidic coiled-coil 1 protein.Deregulation of Aurora kinase gene expression in human testicular germ cell tumours.Q-Elastosonography of Solid Thyroid Nodules: Assessment of Diagnostic Efficacy and Interobserver Variability in a Large Patient CohortAnalysis of clinical, ultrasound and colour flow-Doppler characteristics in predicting malignancy in follicular thyroid neoplasmsPrognostic significance of the age factor in the thyroid cancer: statistical analysisLow value of color flow-doppler in predicting malignancy of thyroid follicular neoplasmsComparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasmAdvanced gallbladder cancer misdiagnosisClinical and ultrasound parameters in the approach to thyroid nodules cytologically classified as indeterminate neoplasmShoulder osteolytic lesion: an unusual presentation of undifferentiated pancreatic carcinomaMetachronous elastofibromasIntestinal neurofibromatosis found on surveillance colonoscopy
P50
Q33559079-24E822C4-B9CA-4CAB-A3EA-3B97C625A6ACQ34029020-9C47EAF9-7758-4032-B263-0FCC21EF6E39Q34500672-440EBBFD-BCC4-4318-8DE0-D69884DE2F89Q35217023-1227EDE3-0EA6-4B35-9DED-1AABA22A4BF2Q35235136-5C8EEF49-FEC5-4ABD-839A-4E0139E0C5FFQ36324723-50F4D2E0-7403-4125-AAEA-4A525D8441D3Q37387695-27925B41-241B-4ADD-826F-D9AC419C05E9Q38215024-D0CB0B7E-CC89-460E-A579-AC5B354B0CEDQ38683603-79EE4E04-2E30-462D-905D-3470DAB6BDB5Q38785223-D110226C-3A5A-4370-9818-FB03FDF27CB6Q38848857-4122BF1A-8B27-40E8-9628-0CB14E595D09Q39004661-39018517-1D11-48CE-B375-46F06461F781Q39019458-37612436-FE39-4C08-AFCE-9AB34E56FC8AQ39148679-5E517765-737D-4C4D-9EA3-C12741F19C14Q39330634-EC5FE980-1CF5-4F03-AE4D-4CF7940DEA1CQ40275379-B59A430C-D697-4A53-AC70-2F99FD20C354Q40457850-8BB3BCEB-C148-4DA2-862D-4C1EAC8AE2F3Q43739642-04233EA3-3797-4B64-935B-293FBEF6F34AQ46256690-B0ABB55A-7BED-4B43-A780-EC7A170BE42DQ48066430-9B179726-C04E-42E7-A6CE-9A0E9C0B93D3Q48075416-5E3323FE-F162-4053-BD3B-CEF923A8FDFCQ48230812-42713B36-E73E-44A2-B4E6-B507839F49EDQ48230830-1F07DB50-6DD0-4319-ACA2-BDF24033A769Q48938520-AA374C04-EDC7-46C2-9219-A823A1A47081Q50195563-749A78A8-3C29-4DF4-BDAF-B8AD0796B3E6Q50646007-951FD071-A856-47C6-9202-17506154328CQ51155587-C362AE01-DD03-46FD-B161-5164CF6D9322Q53070298-B6BDC96F-138A-4D7B-8E9C-4E7B7B55D28BQ53251152-5BE9C1EC-7794-4DE9-BF4A-AC20B5FCDA97Q53312582-AB283F9D-D4B6-4EC0-AAEF-3846A245BB8CQ60601115-D763C077-56DE-404C-A5F9-9472532C92EAQ80220978-21FE06E5-89A6-4650-A9C9-CA0A3D861F4BQ81061576-F3474034-FC0C-4D9F-9787-40E21DA74781Q83349903-BACFC961-0381-47D1-A76C-530D61D6BF08Q83627454-6392D209-7BD1-4F6D-B51A-FDAE764B8E63Q83992888-718893CA-ED78-4C78-AD1B-F423BEB94A81Q84280158-EE4995D0-68DB-4EC5-82DF-446002B1B7E2Q84370591-99D085A1-17AD-41A0-B509-557BC78C2BE9Q86349782-BCCE5F0E-F275-4FBE-BFA5-5C1250911DD9Q89257253-9A46724E-4F7A-4147-A487-548AF5549EE0
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-0427-6648
@en
name
Salvatore Sorrenti
@ast
Salvatore Sorrenti
@en
Salvatore Sorrenti
@es
Salvatore Sorrenti
@nl
type
label
Salvatore Sorrenti
@ast
Salvatore Sorrenti
@en
Salvatore Sorrenti
@es
Salvatore Sorrenti
@nl
prefLabel
Salvatore Sorrenti
@ast
Salvatore Sorrenti
@en
Salvatore Sorrenti
@es
Salvatore Sorrenti
@nl
P106
P1153
6701466630
P31
P496
0000-0003-0427-6648